Steven Eugene Benner
Inventor
Stats
- 4 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 10 US Applications Filed
- 20 Total Citation Count
- Apr 30, 2018 Most Recent Filing
- Oct 18, 2010 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ONCOMED PHARMACEUTICALS, INC. | 2
1 3 2 3 1 | 2010
2011 2013 2014 2016 2017 |
Inventor Addresses
Address | Duration |
---|---|
Oakland, CA, US | Oct 18, 12 - Dec 06, 16 |
SEATTLE, WA, US | Aug 14, 14 - Aug 14, 14 |
Seattle, WA, US | Dec 05, 13 - Dec 22, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 10 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
C07K: | PEPTIDES | 8 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
10870693 | 2020 | Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent | 2 |
2018/0346,556 | 2018 | THERAPEUTIC COMBINATION AND METHODS OF TREATMENT WTIH A DLL4 ANTAGONIST AND AN ANTI-HYPERTENSIVE AGENT | 1 |
9982042 | 2018 | Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent | 3 |
2017/0299,598 | 2017 | Methods and Monitoring of Treatment With A DLL4 Antagonist | 2 |
2017/0166,632 | 2017 | Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.